Please login to the form below

Not currently logged in
Email:
Password:

Oculeve

This page shows the latest Oculeve news and features for those working in and with pharma, biotech and healthcare.

Allergan stumps up $375m for bolt-on acquisitions

Allergan stumps up $375m for bolt-on acquisitions

Allergan stumps up $375m for bolt-on acquisitions. Firm has recently added two migraine drugs and Oculeve to its portfolio. ... Meanwhile, the Oculeve deal "adds novel, complementary dry eye development programmes to Allergan's current eye care R&D,"

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics